Synthesis and Anticancer Cytotoxicity of Azaaurones Overcoming Multidrug Resistance
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthesis and Anticancer Cytotoxicity of Azaaurones Overcoming Multidrug Resistance
Authors
Keywords
-
Journal
MOLECULES
Volume 25, Issue 3, Pages 764
Publisher
MDPI AG
Online
2020-02-12
DOI
10.3390/molecules25030764
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Collateral sensitivity of natural products in drug-resistant cancer cells
- (2019) Thomas Efferth et al. BIOTECHNOLOGY ADVANCES
- Azaaurones as Potent Antimycobacterial Agents Active against MDR‐ and XDR‐TB
- (2019) André Campaniço et al. ChemMedChem
- Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids
- (2019) Qingmei Ye et al. Frontiers in Oncology
- Selective PRMT5 inhibitors suppress human CD8+ T-cells by upregulation of p53 and impairment of the AKT pathway similar to the tumor metabolite MTA
- (2019) Carolin Dorothea Strobl et al. MOLECULAR CANCER THERAPEUTICS
- Anticancer Thiosemicarbazones: Chemical Properties, Interaction with Iron Metabolism, and Resistance Development
- (2018) Petra Heffeter et al. ANTIOXIDANTS & REDOX SIGNALING
- Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
- (2017) Deepali Waghray et al. JOURNAL OF MEDICINAL CHEMISTRY
- Yin and Yang of Polyphenols in Cancer Prevention: A Short Review
- (2016) Jolie Kiemlian Kwee Anti-Cancer Agents in Medicinal Chemistry
- Probing the Azaaurone Scaffold against the Hepatic and Erythrocytic Stages of Malaria Parasites
- (2016) Marta P. Carrasco et al. ChemMedChem
- Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistance
- (2016) Veronika F.S. Pape et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 2-Indolylmethylenebenzofuranones as first effective inhibitors of ABCC2
- (2016) Elisabeta Baiceanu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
- (2016) András Füredi et al. MOLECULAR CANCER THERAPEUTICS
- Synthesis and characterization of the anticancer and metal binding properties of novel pyrimidinylhydrazone derivatives
- (2015) Veronika F.S. Pape et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Targeting the Achilles Heel of Multidrug-Resistant Cancer by Exploiting the Fitness Cost of Resistance
- (2014) Gergely Szakács et al. CHEMICAL REVIEWS
- Collateral sensitivity as a strategy against cancer multidrug resistance
- (2012) Kristen M. Pluchino et al. DRUG RESISTANCE UPDATES
- Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?
- (2012) P. Borst Open Biology
- 1-Azaaurones derived from the naturally occurring aurones as potential antimalarial drugs
- (2010) Florence Souard et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Identification of Compounds Selectively Killing Multidrug-Resistant Cancer Cells
- (2009) D. Turk et al. CANCER RESEARCH
- Synthesis, Activity, and Pharmacophore Development for Isatin-β-thiosemicarbazones with Selective Activity toward Multidrug-Resistant Cells
- (2009) Matthew D. Hall et al. JOURNAL OF MEDICINAL CHEMISTRY
- Is resistance useless? Multidrug resistance and collateral sensitivity
- (2009) Matthew D. Hall et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started